Cyanocobalamin Injection 1,000 mcg/mL Recall: Particulate Matter
Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was Cyanocobalamin Injection 1,000 mcg/mL recalled?
Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59
Which lot codes, UPCs or models are affected?
Lot: 24394A, Exp 10-31-2026
- Agency record number
- D-0173-2027
- Product
- Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint…
- Recalling firm
- American Health Packaging
- Quantity
- 4,097- cartons (25 x 1mL vials)
- Distribution
- Nationwide in the USA
- Recall started
- October 22, 2026
- Report date
- November 11, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)